Difference between revisions of "Citalopram-escitalopram"
From Psychiatrienet
| Line 12: | Line 12: | ||
* Defined Daily Dose es-citalopram: 10 mg | * Defined Daily Dose es-citalopram: 10 mg | ||
* The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect. | * The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect. | ||
| + | {{review}} | ||
}} | }} | ||
Revision as of 14:56, 21 October 2015
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Switch medication from Citalopram to Escitalopram.[1] [2]
Stop Citalopram - stop administration abruptly.
Start Escitalopram- No wash-out period is applied.
- Start escitalopram the next day in half the dosage of citalopram.
More information- Defined Daily Dose citalopram: 20 mg
- Defined Daily Dose es-citalopram: 10 mg
- The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect.
- This switch is currently being reviewed.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
